Literature DB >> 25559415

Cancer statistics, 2015.

Rebecca L Siegel1, Kimberly D Miller, Ahmedin Jemal.   

Abstract

Each year the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries. Mortality data were collected by the National Center for Health Statistics. A total of 1,658,370 new cancer cases and 589,430 cancer deaths are projected to occur in the United States in 2015. During the most recent 5 years for which there are data (2007-2011), delay-adjusted cancer incidence rates (13 oldest SEER registries) declined by 1.8% per year in men and were stable in women, while cancer death rates nationwide decreased by 1.8% per year in men and by 1.4% per year in women. The overall cancer death rate decreased from 215.1 (per 100,000 population) in 1991 to 168.7 in 2011, a total relative decline of 22%. However, the magnitude of the decline varied by state, and was generally lowest in the South (∼15%) and highest in the Northeast (≥20%). For example, there were declines of 25% to 30% in Maryland, New Jersey, Massachusetts, New York, and Delaware, which collectively averted 29,000 cancer deaths in 2011 as a result of this progress. Further gains can be accelerated by applying existing cancer control knowledge across all segments of the population.
© 2015 American Cancer Society.

Entities:  

Keywords:  cancer cases; cancer statistics; death rates; incidence; mortality; survival; trends

Mesh:

Year:  2015        PMID: 25559415     DOI: 10.3322/caac.21254

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  2000 in total

1.  Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.

Authors:  Yang Su; Jingxiao Lu; Xianguo Chen; Chaozhao Liang; Pengcheng Luo; Cong Qin; Jie Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2018-12-03       Impact factor: 4.553

2.  Multi-parametric MRI in cervical cancer: early prediction of response to concurrent chemoradiotherapy in combination with clinical prognostic factors.

Authors:  Wei Yang; Jin Wei Qiang; Hai Ping Tian; Bing Chen; Ai Jun Wang; Jian Guo Zhao
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

Review 3.  Management of Urethral Stricture and Bladder Neck Contracture Following Primary and Salvage Treatment of Prostate Cancer.

Authors:  Brendan Michael Browne; Alex J Vanni
Journal:  Curr Urol Rep       Date:  2017-10       Impact factor: 3.092

Review 4.  Review of the progress toward achieving heat confinement-the holy grail of photothermal therapy.

Authors:  Wangzhong Sheng; Sha He; William J Seare; Adah Almutairi
Journal:  J Biomed Opt       Date:  2017-08-01       Impact factor: 3.170

5.  Nedaplatin and paclitaxel compared with carboplatin and paclitaxel for patients with platinum-sensitive recurrent ovarian cancer.

Authors:  Li Ge; Ning Li; Guang-Wen Yuan; Yang-Chun Sun; Ling-Ying Wu
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

6.  Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study.

Authors:  Rebecca Pedersini; Lucia Vassalli; Melanie Claps; Antonella Tulla; Filippo Rodella; Salvatore Grisanti; Vito Amoroso; Elisa Roca; Edda Lucia Simoncini; Alfredo Berruti
Journal:  Oncology       Date:  2018-07-23       Impact factor: 2.935

7.  MicroRNA-520d-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting PTTG1.

Authors:  Tongle Zhi; Kuan Jiang; Xiupeng Xu; Tianfu Yu; Weining Wu; Er Nie; Xu Zhou; Xin Jin; Junxia Zhang; Yingyi Wang; Ning Liu
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

8.  Aberrant SIRT6 expression contributes to melanoma growth: Role of the autophagy paradox and IGF-AKT signaling.

Authors:  Liwen Wang; Weinan Guo; Jinyuan Ma; Wei Dai; Lin Liu; Sen Guo; Jiaxi Chen; Huina Wang; Yuqi Yang; Xiuli Yi; Gang Wang; Tianwen Gao; Guannan Zhu; Chunying Li
Journal:  Autophagy       Date:  2017-12-31       Impact factor: 16.016

9.  Effect of serum interleukin-1 receptor antagonist level on survival of patients with non-small cell lung cancer.

Authors:  Murat Yigit; Serkan Değirmencioğlu; Erhan Ugurlu; Arzu Yaren
Journal:  Mol Clin Oncol       Date:  2017-03-15

10.  Breast Cancer Survivors' Contribution to Psychosocial Adjustment of Newly Diagnosed Breast Cancer Patients in a Computer-Mediated Social Support Group.

Authors:  Tae-Joon Moon; Ming-Yuan Chih; Dhavan V Shah; Woohyun Yoo; David H Gustafson
Journal:  Journal Mass Commun Q       Date:  2017-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.